-
1 Comment
BuzBuz Capital Corp is currently in a long term downtrend where the price is trading 0.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
BuzBuz Capital Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 282.1% to $-8K since the same quarter in the previous year.
Finally, its free cash flow fell by 2470.7% to $-52K since the same quarter in the previous year.
Based on the above factors, BuzBuz Capital Corp gets an overall score of 1/5.
| Exchange | V |
|---|---|
| CurrencyCode | CAD |
| ISIN | None |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market Cap | 2M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 3.29 |
| Dividend Yield | None |
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection systems for the administration of subcutaneous medication. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BZBZ-P.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
